[HTML][HTML] Partial oral versus intravenous antibiotic treatment of endocarditis

…, C Torp-Pedersen, J Helweg-Larsen… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with infective endocarditis on the left side of the heart are typically treated
with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to …

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

…, WJG Melchers, J Helweg-Larsen… - Journal of …, 2016 - academic.oup.com
The 5th European Conference on Infections in Leukaemia (ECIL-5) meeting aimed to
establish evidence-based recommendations for the prophylaxis of Pneumocystis jirovecii …

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia

J Helweg-Larsen, TL Benfield, J Eugen-Olsen… - The Lancet, 1999 - thelancet.com
Jannik Helweg-Larsen contributed to the design of the study and analysis of the samples
by sequencing, and wrote the initial draft. Thomas L Benfield contributed to the collection and …

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

…, WJG Melchers, J Helweg-Larsen… - Journal of …, 2016 - academic.oup.com
The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a meeting to
establish evidence-based recommendations for using tests to diagnose Pneumocystis …

[HTML][HTML] Pyogenic brain abscess, a 15 year survey

J Helweg-Larsen, A Astradsson, H Richhall… - BMC infectious …, 2012 - Springer
Background Brain abscess is a potentially fatal disease. This study assesses clinical aspects
of brain abscess in a large hospital cohort. Methods Retrospective review of adult patients …

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

G Maschmeyer, J Helweg-Larsen… - Journal of …, 2016 - academic.oup.com
The initiation of systemic antimicrobial treatment of Pneumocystis jirovecii pneumonia (PCP)
is triggered by clinical signs and symptoms, typical radiological and occasionally laboratory …

Update on Pneumocystis carinii f. sp.hominis Typing Based on Nucleotide Sequence Variations in Internal Transcribed Spacer Regions of rRNA Genes

CH Lee, J Helweg-Larsen, X Tang, S Jin… - Journal of clinical …, 1998 - Am Soc Microbiol
Pneumocystis carinii f. sp. hominisisolates from 207 clinical specimens from nine countries
were typed based on nucleotide sequence variations in the internal transcribed spacer …

[HTML][HTML] Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance

…, M Rabodonirina, J Helweg-Larsen - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected
persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are …

Diagnostic Use of PCR for Detection ofPneumocystis carinii in Oral Wash Samples

J Helweg-Larsen, J Skov Jensen… - Journal of clinical …, 1998 - Am Soc Microbiol
There is a need to develop noninvasive methods for the diagnosis ofPneumocystis carinii
pneumonia in patients unable to undergo bronchoscopy or induction sputum. Oral wash …

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

…, WJG Melchers, J Helweg-Larsen… - Journal of …, 2016 - academic.oup.com
Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for
haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia (PCP) in …